| Literature DB >> 28078134 |
Scott M Thompson1, Benjamin Zendejas-Mummert2, Mindy L Hartgers3, Sudhakar K Venkatesh1, Thomas C Smyrk4, Amit Mahipal3, Rory L Smoot2.
Abstract
Biliary adenofibromas (BAFs) are rare, benign biliary cystic tumors with potential for malignant transformation. Of the eleven prior cases of BAF reported in the literature, six showed evidence of malignant transformation. We describe the clinical, imaging and pathology features of two cases of malignant BAF and review the existing literature to raise awareness of this entity and provide additional tools for diagnosing this rare tumor Additionally, we identified a loss of function mutation in the cyclin-dependent kinase inhibitor 2A (CDKN2A) tumor suppressor gene in a malignant caudate lobe BAF, thereby providing potential insight into the molecular pathogenesis of BAF malignant transformation. Although additional cases and longer-term follow-up are needed, our cases suggest that recurrence or metastasis of malignant BAF is not common and that complete surgical resection can be curative.Entities:
Keywords: Biliary adenofibroma (BAF); caudate lobe; malignant transformation; next generation sequencing; tumor suppressor
Year: 2016 PMID: 28078134 PMCID: PMC5177566 DOI: 10.21037/jgo.2016.09.14
Source DB: PubMed Journal: J Gastrointest Oncol ISSN: 2078-6891